Thorne Healthtech, Inc. (THRN): Price and Financial Metrics
GET POWR RATINGS... FREE!
THRN Stock Price Chart Interactive Chart >
THRN Price/Volume Stats
| Current price | $5.00 | 52-week high | $10.13 |
| Prev. close | $4.66 | 52-week low | $4.00 |
| Day low | $4.68 | Volume | 36,100 |
| Day high | $5.01 | Avg. volume | 83,839 |
| 50-day MA | $5.11 | Dividend yield | N/A |
| 200-day MA | $5.49 | Market Cap | 263.71M |
Thorne Healthtech, Inc. (THRN) Company Bio
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health. It serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
Latest THRN News From Around the Web
Below are the latest news stories about THORNE HEALTHTECH INC that investors may wish to consider to help them evaluate THRN as an investment opportunity.
THORNE AND TEAM LIQUID ANNOUNCE PARTNERSHIP BRINGING INNOVATIVE HEALTH AND WELLNESS SOLUTIONS TO THE ESPORTS COMMUNITYThorne HealthTech ("Thorne") (NASDAQ: THRN), the leader in developing innovative solutions for a personalized approach to health and wellness and Team Liquid, a leading worldwide professional esports organization, today announced that Thorne is now the official Health and Wellness Partner of Team Liquid. |
Investors in Thorne HealthTech (NASDAQ:THRN) have unfortunately lost 34% over the last yearPassive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you... |
Thorne HealthTech's OneDraw™ Blood Collection Device Receives PMDA Certification in JapanThorne HealthTech, Inc. ("Thorne HealthTech" or "Thorne") (NASDAQ: THRN), a leader in developing innovative solutions for a personalized approach to health and wellness and majority owner of Drawbridge Health announced today that its OneDraw™ Blood Collection Device has been certified in Japan as a medical device, having been cleared by the Pharmaceutical and Medical Devices Agency (PMDA). |
Quite a few insiders invested in Thorne HealthTech, Inc. (NASDAQ:THRN) last year which is positive news for shareholdersWhen a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase... |
Thorne HealthTech, Inc. (THRN) Q2 2022 Earnings Call TranscriptThank you for joining Thorne HealthTech's second quarter 2022 earnings call. With me today to share our results are Paul Jacobson, our CEO; and Bryan Conley, our CFO. Tom McKenna, our COO; and Michelle Crow, our chief Marketing officer are also available for questions. |
THRN Price Returns
| 1-mo | N/A |
| 3-mo | 6.61% |
| 6-mo | -24.01% |
| 1-year | -37.73% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -19.48% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...